Caption Management, LLC Akero Therapeutics, Inc. Put Options Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$21.45 - $29.34 $911,625 - $1.25 Million	42,500 New	42,500 $1.22 Million
Q1 2024 May 15, 2024	BUY	$17.76 - $31.18 $5.27 Million - $9.24 Million	296,500 New	296,500 $7.49 Million
Q3 2023 Nov 14, 2023	BUY	$41.19 - $52.25 $4.65 Million - $5.9 Million	113,000 Added 376.67%	143,000 $7.23 Million
Q2 2023 Aug 14, 2023	SELL	$36.89 - $56.88 $1.11 Million - $1.71 Million	-30,000 Reduced 50.0%	30,000 $1.4 Million
Q1 2023 May 15, 2023	BUY	$37.27 - $50.24 $1.12 Million - $1.51 Million	30,000 Added 100.0%	60,000 $2.3 Million
Q4 2022 Feb 14, 2023	SELL	$33.44 - $54.8 $6.55 Million - $10.7 Million	-195,800 Reduced 86.71%	30,000 $1.64 Million
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $2.29 Million - $7.69 Million	225,800 New	225,800 $7.69 Million

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.49B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.